Table 1 Univariate analysis of baseline characteristics between patients with and without rebleeding
No rebleeding (n = 1357) | Rebleeding (n = 146) | P value | |
|---|---|---|---|
Age | 52.9 ± 13.0 | 54.6 ± 13.3 | 0.144 |
Gender (Male) | 907 (66.8) | 98 (67.1) | 1 |
Child-Pugh class | < 0.001 | ||
A | 455 (33.5) | 19 (13.0) | |
B | 639 (47.1) | 76 (52.1) | |
C | 263 (19.4) | 51 (34.9) | |
Hepatic encephalopathy | 94 (6.9) | 29 (19.9) | < 0.001 |
Ascites | 699 (51.5) | 51 (34.9) | < 0.001 |
Source of Bleeding | |||
Varices lesion | 1154 (85.0) | 121 (82.9) | 0.568 |
Non-varices lesion | 96 (7.1) | 4 (2.7) | 0.068 |
Lower gastrointestinal lesion | 43 (3.2) | 4 (2.7) | 0.974 |
Unidentified lesion | 108 (8.0) | 20 (13.7) | 0.027 |
Bilirubin (umol/L) a | 32.5 ± 40.6 | 48.4 ± 88.4 | < 0.001 |
Albumin (g/L) a | 31.0 ± 6.1 | 27.8 ± 6.6 | < 0.001 |
Creatine (mol/L) a | 80.6 ± 60.3 | 90.1 ± 58.5 | 0.071 |
Hemoglobin (g/L) a | 75.8 ± 22.9 | 73.7 ± 22.3 | 0.274 |
Prothrombin time (s) a | 16.6 ± 9.7 | 18.3 ± 10.5 | 0.038 |
Balloon tamponade | 95 (7.0) | 74 (50.7) | < 0.001 |
Endoscopic treatment | 489 (36.0) | 22 (15.1) | < 0.001 |
Radiological intervention | 336 (24.8) | 46 (31.5) | 0.093 |